LSV Asset Management’s Lifecore Biomedical LFCR Stock Holding History

LSV Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,100	Closed	-$43K	–	1113
2016 Q1	$43K	Hold	4,100	–	–	﹤0.01%	999
2015 Q4	$48K	Buy	+4,100	New	+$50.4K	﹤0.01%	973
2015 Q2	–	Sell	-8,300	Closed	-$115K	–	956
2015 Q1	$115K	Hold	8,300	–	–	﹤0.01%	845
2014 Q4	$114K	Sell	8,300 -4,700	-36%	-$60.7K	﹤0.01%	853
2014 Q3	$159K	Hold	13,000	–	–	﹤0.01%	831
2014 Q2	$162K	Hold	13,000	–	–	﹤0.01%	807
2014 Q1	$145K	Hold	13,000	–	–	﹤0.01%	797
2013 Q4	$157K	Hold	13,000	–	–	﹤0.01%	813
2013 Q3	$158K	Hold	13,000	–	–	﹤0.01%	881
2013 Q2	$171K	Buy	+13,000	New	+$180K	﹤0.01%	801

Other funds holding LFCR

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management's LFCR Position: Q2 2016 in Review

LSV Asset Management sold out of Lifecore Biomedical (LFCR) in Q2 2016, closing a stake of 4,100 shares — an estimated $43K sold.

LSV Asset Management first reported a position in LFCR in Q2 2013 and held it in 10 quarters. The position peaked at $171K in Q2 2013. 97 funds tracked by Wall St. Rank hold LFCR as of Q2 2016.

LSV Asset Management reported no remaining Lifecore Biomedical position as of Q2 2016 after selling out during the quarter.
LSV Asset Management sold 4,100 Lifecore Biomedical shares in Q2 2016, an estimated $43K.
LSV Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 10 quarters.
LSV Asset Management's Lifecore Biomedical position peaked at $171K in Q2 2013.
97 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2016.

Based on LSV Asset Management's 13F filing for Q2 2016, filed 5 Aug 2016.